Tornandizo, Melecio A.
HRN: 02-35-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFTRIAXONE 1G (VIAL)
03/13/2024
03/20/2024
IV
2g
Q24
Anterior Shoulder Dislocation Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes